✦ LIBER ✦
Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy
✍ Scribed by Brian I. Rini; Vivian Weinberg; Lawrence Fong; Shauna Conry; Robert M. Hershberg; Eric J. Small
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 125 KB
- Volume
- 107
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.